Reviva Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Reviva Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RVPH | Reviva Pharmaceuticals | -$0.25 | -$0.11 | — | — | $0.00 | — | — | — | 11/13/2025 | |
RVPH | Reviva Pharmaceuticals | -$0.26 | -$0.13 | -$0.12 | 7.69% | $0.00 | — | $0.00 | — | 08/14/2025 | |
RVPH | Reviva Pharmaceuticals | -$0.25 | -$0.19 | -$0.13 | 31.58% | $0.00 | — | $0.00 | — | 05/15/2025 | |
RVPH | Reviva Pharmaceuticals | -$0.35 | -$0.21 | -$0.15 | 28.57% | $0.00 | — | $0.00 | — | 03/31/2025 | |
RVPH | Reviva Pharmaceuticals | -$0.48 | -$0.25 | -$0.25 | 0.00% | $0.00 | — | $0.00 | — | 11/14/2024 | |
RVPH | Reviva Pharmaceuticals | -$0.55 | -$0.29 | -$0.26 | 10.34% | $0.00 | — | $0.00 | — | 08/14/2024 | |
RVPH | Reviva Pharmaceuticals | -$0.31 | -$0.42 | -$0.25 | 40.48% | $0.00 | — | $0.00 | — | 05/14/2024 | |
RVPH | Reviva Pharmaceuticals | -$0.38 | -$0.32 | -$0.35 | -9.38% | $0.00 | — | $0.00 | — | 04/15/2024 | |
RVPH | Reviva Pharmaceuticals | -$0.18 | -$0.37 | -$0.44 | -18.92% | $0.00 | — | $0.00 | — | 11/14/2023 | |
RVPH | Reviva Pharmaceuticals | -$0.29 | -$0.28 | -$0.55 | -96.43% | $0.00 | — | $0.00 | — | 08/14/2023 | |
RVPH | Reviva Pharmaceuticals | -$0.40 | -$0.32 | -$0.30 | 6.25% | $0.00 | — | $0.00 | — | 05/15/2023 | |
RVPH | Reviva Pharmaceuticals | -$0.24 | -$0.22 | -$0.38 | -72.73% | $0.00 | — | $0.00 | — | 03/30/2023 | |
RVPH | Reviva Pharmaceuticals | -$0.12 | -$0.29 | -$0.18 | 37.93% | $0.00 | — | $0.00 | — | 11/14/2022 | |
RVPH | Reviva Pharmaceuticals | -$0.12 | -$0.30 | -$0.29 | 3.33% | $0.00 | — | $0.00 | — | 08/15/2022 | |
RVPH | Reviva Pharmaceuticals | -$0.10 | -$0.28 | -$0.40 | -42.86% | $0.00 | — | $0.00 | — | 05/16/2022 | |
RVPH | Reviva Pharmaceuticals | — | -$0.25 | -$0.24 | 4.00% | — | — | $0.00 | — | 03/15/2022 | |
RVPH | Reviva Pharmaceuticals | -$0.24 | -$0.23 | -$0.12 | 47.83% | $0.00 | — | $0.00 | — | 11/15/2021 | |
RVPH | Reviva Pharmaceuticals | -$0.58 | -$0.24 | -$0.12 | 50.00% | $0.00 | — | $0.00 | — | 08/16/2021 | |
RVPH | Reviva Pharmaceuticals | — | — | -$0.10 | — | — | — | $0.00 | — | 05/17/2021 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.12 | $-0.13 | 7.69 % |
| Q1 | 2025-05-15 | $-0.13 | $-0.19 | 31.6 % |
| Q4 | 2025-03-31 | $-0.15 | $-0.21 | 28.6 % |
| Q3 | 2024-11-14 | $-0.25 | $-0.25 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
Está previsto que Reviva Pharmaceuticals (RVPH) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
El BPA real fue de $-0.12, que superó la estimación de $-0.13.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.